Compounds > aica ribonucleotide

aica ribonucleotide and 4-butyrolactone

aica ribonucleotide has been researched along with 4-butyrolactone in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aja, S; Kim, EK; Kuhajda, FP; Landree, LE; McFadden, J; Miller, I; Moran, TH; Pinn, M; Ronnett, GV	1
Landree, LE; Li, H; McCullough, LD; McFadden, J; Ronnett, GV; Zeng, Z	1
Aja, S; Kleman, AM; Landree, LE; Ronnett, GV; Yuan, JY	1
Downs, SM; Klinger, J; Mosey, JL	1

Other Studies

4 other study(ies) available for aica ribonucleotide and 4-butyrolactone

Article	Year
C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. The Journal of biological chemistry, 2004, May-07, Volume: 279, Issue:19 Topics: 4-Butyrolactone; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Blotting, Northern; Blotting, Western; Eating; Fatty Acid Synthases; Feeding Behavior; Hypothalamus; Image Processing, Computer-Assisted; Immunohistochemistry; In Situ Hybridization; Male; Mice; Mice, Inbred BALB C; Models, Biological; Multienzyme Complexes; Neurons; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Ribonucleotides; RNA; Time Factors	2004
Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. The Journal of biological chemistry, 2005, May-27, Volume: 280, Issue:21 Topics: 4-Butyrolactone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain Ischemia; Cerebral Cortex; Constriction; Disease Models, Animal; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Fatty Acid Synthases; Glucose; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Cerebral Artery; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxygen; Protein Serine-Threonine Kinases; Rats; Ribonucleotides; Stroke	2005
Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. Journal of neuroscience methods, 2008, Jan-30, Volume: 167, Issue:2 Topics: 4-Butyrolactone; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Glucose; Hypoglycemic Agents; Multienzyme Complexes; Neurons; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Ribonucleotides; Time Factors	2008
Fatty acid oxidation and meiotic resumption in mouse oocytes. Molecular reproduction and development, 2009, Volume: 76, Issue:9 Topics: 4-Butyrolactone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Cerulenin; Cumulus Cells; Epoxy Compounds; Fatty Acids; Female; Malonyl Coenzyme A; Meiosis; Mice; Mice, Inbred C57BL; Oocytes; Oxidation-Reduction; Palmitic Acid; Ribonucleotides	2009